GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Acotec Scientific Holdings Ltd (STU:7W3) » Definitions » Additional Paid-In Capital

Acotec Scientific Holdings (STU:7W3) Additional Paid-In Capital : €179.71 Mil(As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Acotec Scientific Holdings Additional Paid-In Capital?


Acotec Scientific Holdings's quarterly additional paid-in capital declined from Dec. 2023 (€175.96 Mil) to Jun. 2024 (€175.45 Mil) but then increased from Jun. 2024 (€175.45 Mil) to Dec. 2024 (€179.71 Mil).

Acotec Scientific Holdings's annual additional paid-in capital declined from Dec. 2022 (€185.52 Mil) to Dec. 2023 (€175.96 Mil) but then increased from Dec. 2023 (€175.96 Mil) to Dec. 2024 (€179.71 Mil).


Acotec Scientific Holdings Additional Paid-In Capital Historical Data

The historical data trend for Acotec Scientific Holdings's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acotec Scientific Holdings Additional Paid-In Capital Chart

Acotec Scientific Holdings Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Additional Paid-In Capital
Get a 7-Day Free Trial - 190.37 185.52 175.96 179.71

Acotec Scientific Holdings Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 185.52 176.58 175.96 175.45 179.71

Acotec Scientific Holdings Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Acotec Scientific Holdings Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Acotec Scientific Holdings's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Acotec Scientific Holdings Business Description

Traded in Other Exchanges
Address
16 North Hongda Road, 4-5th Floor, Building No. 1, Beijing Economic-Technological Development Area, Beijing, CHN
Acotec Scientific Holdings Ltd is a medical technology company, focusing on the research and development, and application of technology platforms in the field of vascular interventional treatment. Its product portfolio comprises Semi-compliant PTCA balloon (YAN), Coronary CTO Recanalization Balloon (RT-Zero), Coronary CTO Antegrade Micro-Catheter (Vericor-14), Coronary High-Pressure Balloon (YIYAN), Coronary CTO Retrograde Micro-Catheter (Vericor-RS), Cardiac Valve Balloon Dilation Catheter (RunFlow), etc., and also has various other products in its development pipeline. Geographically, the company generates a majority of its revenue from Mainland China, and the rest from other regions.

Acotec Scientific Holdings Headlines

No Headlines